Literature DB >> 23988268

The role played by the microenvironment in site-specific metastasis.

Anat Klein-Goldberg1, Shelly Maman2, Isaac P Witz3.   

Abstract

Cancer cells that disseminate to metastatic sites may progress to frank metastasis or persist as dormant micrometastasis. Significant progress has been made in defining the genetic and phenotypic cancer-cell-autonomous determinants of metastasis and in the understanding of the cross-talk between metastasizing tumor cells and the metastatic microenvironment. However several questions remain open, in particular the identity of microenvironmental factors that keep micrometastatic cells in a state of dormancy and those that promote survival, proliferation and progression of such cells. Significantly more information is available on the latter factors than on microenvironmental cells and molecules that restrain micrometastasis. This mini-review summarizes findings suggesting that: In view of the above, it is not unlikely that metastases residing in different microenvironments may require "individualized" treatment modalities.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dormancy; Metastasis; Microenvironment; Micrometastasis

Mesh:

Year:  2013        PMID: 23988268     DOI: 10.1016/j.canlet.2013.08.029

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  26 in total

1.  Dural Cells Release Factors Which Promote Cancer Cell Malignancy and Induce Immunosuppressive Markers in Bone Marrow Myeloid Cells.

Authors:  Nicholas J Szerlip; Alexandra Calinescu; Eleanor Smith; Rebecca Tagett; Katrina L Clines; Henry H Moon; Russell S Taichman; Catherine H Van Poznak; Gregory A Clines
Journal:  Neurosurgery       Date:  2018-12-01       Impact factor: 4.654

2.  Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.

Authors:  Dongwei Gao; Sha Li
Journal:  Cancer Microenviron       Date:  2013-11-10

3.  Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β2.

Authors:  Linghui Nie; Orestis Lyros; Rituparna Medda; Nebojsa Jovanovic; Jamie L Schmidt; Mary F Otterson; Christopher P Johnson; Behnaz Behmaram; Reza Shaker; Parvaneh Rafiee
Journal:  Am J Physiol Cell Physiol       Date:  2014-08-27       Impact factor: 4.249

4.  Tumor-associated fibroblasts predominantly come from local and not circulating precursors.

Authors:  Ainhoa Arina; Christian Idel; Elizabeth M Hyjek; Maria-Luisa Alegre; Ying Wang; Vytautas P Bindokas; Ralph R Weichselbaum; Hans Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-17       Impact factor: 11.205

5.  The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancer.

Authors:  Nigel T Brockton; Stephanie J Gill; Stephanie L Laborge; Alexander H G Paterson; Linda S Cook; Hans J Vogel; Carrie S Shemanko; David A Hanley; Anthony M Magliocco; Christine M Friedenreich
Journal:  BMC Cancer       Date:  2015-07-10       Impact factor: 4.430

6.  Hexokinase 2 is a determinant of neuroblastoma metastasis.

Authors:  Liat Edry Botzer; Shelly Maman; Orit Sagi-Assif; Tsipi Meshel; Ido Nevo; Ilana Yron; Isaac P Witz
Journal:  Br J Cancer       Date:  2016-03-17       Impact factor: 7.640

7.  CCR4 is a determinant of melanoma brain metastasis.

Authors:  Anat Klein; Orit Sagi-Assif; Tsipi Meshel; Alona Telerman; Sivan Izraely; Shlomit Ben-Menachem; Jagadeesh Bayry; Diego M Marzese; Shuichi Ohe; Dave S B Hoon; Neta Erez; Isaac P Witz
Journal:  Oncotarget       Date:  2017-05-09

8.  Combinatorial Discovery of Defined Substrates That Promote a Stem Cell State in Malignant Melanoma.

Authors:  Douglas Zhang; Junmin Lee; Michael B Sun; Yi Pei; James Chu; Martha U Gillette; Timothy M Fan; Kristopher A Kilian
Journal:  ACS Cent Sci       Date:  2017-04-26       Impact factor: 14.553

Review 9.  Cancer drug resistance induced by EMT: novel therapeutic strategies.

Authors:  Javier De Las Rivas; Anamaria Brozovic; Sivan Izraely; Alba Casas-Pais; Isaac P Witz; Angélica Figueroa
Journal:  Arch Toxicol       Date:  2021-05-18       Impact factor: 5.153

10.  PHOX2B is a suppressor of neuroblastoma metastasis.

Authors:  Osnat Naftali; Shelly Maman; Tsipi Meshel; Orit Sagi-Assif; Ravit Ginat; Isaac P Witz
Journal:  Oncotarget       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.